BIOMAT Database Logo BIOMAT Database Logo

Measurement in human sera of antibodies to lipopolysaccharide of Escherichia coli J5. 1987

B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Department of Medical Microbiology, School of Medicine, Vrije Universiteit, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Immunochemical specificity of cross-reactive antibodies to lipopolysaccharide from Escherichia coli J5.
May 1987, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
January 1989, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Prophylactic role for antibodies to Escherichia coli J5.
January 1987, Lancet (London, England),
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Characterization of murine monoclonal antibodies to Escherichia coli J5.
April 1986, Infection and immunity,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Antibody response to Escherichia coli J5 lipopolysaccharide in patients with bacteremia.
May 1987, Microbial pathogenesis,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Enhancement of complement-mediated killing of Neisseria gonorrhoeae by antibodies to lipopolysaccharide of Escherichia coli J5.
March 1993, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.
September 1986, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry.
October 1992, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
June 1985, The Journal of infectious diseases,
B Appelmelk, and P Gruteke, and M Verweij-van Vught, and J Maaskant, and B Thijs, and D MacLaren
Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine.
October 1995, Journal of dairy science,
Copied contents to your clipboard!